These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 2502567)

  • 1. Topical 2% mupirocin versus 2% fusidic acid ointment in the treatment of primary and secondary skin infections.
    Gilbert M
    J Am Acad Dermatol; 1989 Jun; 20(6):1083-7. PubMed ID: 2502567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical antibiotics in the treatment of superficial skin infections in general practice--a comparison of mupirocin with sodium fusidate.
    White DG; Collins PO; Rowsell RB
    J Infect; 1989 May; 18(3):221-9. PubMed ID: 2501394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of sodium fusidate ointment and mupirocin ointment in superficial skin sepsis.
    Morley PA; Munot LD
    Curr Med Res Opin; 1988; 11(2):142-8. PubMed ID: 3146465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical 2% mupirocin versus 2% sodium fusidate ointment in the treatment of primary and secondary skin infections.
    Johnston C
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):797-8. PubMed ID: 1907980
    [No Abstract]   [Full Text] [Related]  

  • 5. [Comparative double-blind evaluation of a new topical antibacterial agent, mupirocin, compared with placebo in the treatment of skin and soft tissue infections].
    Colin M; Avon P
    Pharmatherapeutica; 1988; 5(3):198-203. PubMed ID: 3129741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mupirocin (2 percent) ointment in the treatment of primary and secondary skin infections.
    Odom RB
    Cutis; 1989 Jun; 43(6):599-601. PubMed ID: 2501071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of 2% mupirocin ointment in the treatment of primary and secondary skin infections--an open multicentre trial.
    Bork K; Brauers J; Kresken M
    Br J Clin Pract; 1989 Aug; 43(8):284-8. PubMed ID: 2516463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the new topical antibiotic mupirocin ('Bactroban') with oral antibiotics in the treatment of skin infections in general practice.
    Villiger JW; Robertson WD; Kanji K; Ah Chan M; Fetherston J; Hague IK; Haycock D; Hunter P
    Curr Med Res Opin; 1986; 10(5):339-45. PubMed ID: 3102167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fusidic acid in skin and soft tissue infections.
    Spelman D
    Int J Antimicrob Agents; 1999 Aug; 12 Suppl 2():S59-66. PubMed ID: 10528787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative double-blinded study between mupirocin and tetracycline ointments for treating skin infections.
    Wong KS; Lim KB; Tham SN; Ling ML; Tan T
    Singapore Med J; 1989 Aug; 30(4):380-3. PubMed ID: 2510312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusidic acid in dermatology: an updated review.
    Schöfer H; Simonsen L
    Eur J Dermatol; 2010; 20(1):6-15. PubMed ID: 20007058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical mupirocin against an experimental Staphylococcus aureus surgical wound infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1985 Oct; 16(4):519-26. PubMed ID: 3934130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
    Gisby J; Bryant J
    Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonic acid--a new antibiotic for skin infections.
    Reilly GD; Spencer RC
    J Antimicrob Chemother; 1984 Mar; 13(3):295-8. PubMed ID: 6427173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mupirocin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.
    Ward A; Campoli-Richards DM
    Drugs; 1986 Nov; 32(5):425-44. PubMed ID: 3098541
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical mupirocin in the treatment of bacterial skin infections.
    Rumsfield J; West DP; Aronson IK
    Drug Intell Clin Pharm; 1986 Dec; 20(12):943-8. PubMed ID: 3102197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infections after photodynamic therapy in Condyloma acuminatum patients: incidence and management.
    Yu X; Zheng H
    Environ Sci Pollut Res Int; 2018 May; 25(14):14000-14005. PubMed ID: 29516425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and bacteriological efficacy of mupirocin (Bactroban): a new topical antibiotic.
    Gould PW; Villiger JW
    N Z Med J; 1986 Jul; 99(805):516. PubMed ID: 3090486
    [No Abstract]   [Full Text] [Related]  

  • 19. An evaluation of topical mupirocin in moderately severe primary and secondary skin infections.
    Buchvald J
    J Int Med Res; 1988; 16(1):66-70. PubMed ID: 3127257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term effects of topical fusidic acid or mupirocin on the prevalence of fusidic acid resistant (FusR) Staphylococcus aureus in atopic eczema.
    Ravenscroft JC; Layton AM; Eady EA; Murtagh MS; Coates P; Walker M; Cove JH
    Br J Dermatol; 2003 May; 148(5):1010-7. PubMed ID: 12786834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.